Permanent pacemakers and implantable defibrillators: Considerations for intensivists

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 9, 2004, Pages 933-940

  McPherson, Craig A ^a   Manthous, Constantine ^a  

^a BRIDGEPORT HOSPITAL   (United States)

Author keywords

Arrhythmia; Critical care; Implantable cardiac defibrillator; Pacemaker

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR DISEASE; CARDIOVERSION; CRITICAL ILLNESS; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; ELECTROMAGNETIC RADIATION; HEART ELECTROPHYSIOLOGY; HEMODYNAMICS; HUMAN; IMPLANT; MAGNETIC FIELD; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW;

ARRHYTHMIA; CRITICAL CARE; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; EQUIPMENT FAILURE; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PACEMAKER, ARTIFICIAL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 7044231574     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200402-211UP     Document Type: Review

References (20)

1. Elmqvist R. Review of early pacemaker development. Pacing Clin Electrophysiol 1978;1:535-536.
2. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, et al. Termination of malignant ventricular arrhythmias with an implanted automatic ICD in human beings. N Engl J Med 1980;303:322-324.
3. The DAVID Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable ICD: the dual chamber and VVI implantable ICD (DAVID) trial. JAMA 2002;288:3115-3123.
4. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA. Mode Selection Trial Investigators: adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-2937.
5. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val-Mejias J, Mackall J, et al. Atrial Dynamic Overdrive Pacing Trial (ADOPT) Investigators: a new pacemaker algorithm for the treatment of atrial fibrillation: results of the atrial dynamic overdrive pacing trial (ADOPT). J Am Coll Cardiol 2003; 42:627-633.
6. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, Ryan T, Reller LB, Fowler VG Jr. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001;104:1029-1033.
7. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, et al. MOST Investigators: atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the mode selection trial (MOST) trial. Circulation 2003;107: 1614-1619.
8. Kindermann M, Frohlig G, Doerr T, Schleffer H. Optimizing the AV delay in DDD pacemaker patients with high degree AV block: mitral valve Doppler versus impedance cardiography. Pacing Clin Electrophysiol 1997;20:2453-2462.
9. Rowe GG, Stenlund RR, Thomsen JH, Terry W, Querimit AS. Coronary and systemic hemodynamic effects of cardiac pacing in man with complete heart block. Circulation 1969;XL:839-845.
10. Friesen WG. Sequential circulatory changes following acute myocardial infarction in man: determination of optimal heart rate at each stage of the infarction by atrial pacing. Circulation 1973;47:465-475.
11. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB Jr, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31: 1175-1209.
12. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmic devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines). J Am Coll Cardiol 2002;40: 1703-1719.
13. Sogaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BO, Mortensen PT. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002;40: 723-730.
14. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2002;91:684-688.
15. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, De Spirito S, Guerra R, Patruno N, Serra F. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol 2003;42:2117-2124.
16. Kass D. Predicting cardiac resynchronization response by QRS duration [editorial]. J Am Coll Cardiol 2003;42:2125-2127.
17. Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq C, Schalij MJ, Sogaard P, St John Sutton M, Nihoyannopoulos P. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? J Am Coll Cardiol 2004;44:1-9.
18. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
19. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators: prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158.
20. Bardy GH, Lee KL, Mark DB. Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT). American College of Cardiology Annual Scientific Sessions, New Orleans 2004: Late Breaking Trial. New Orleans, LA; March 7-10, 2004.